ENDRA Life Sciences (NDRA) Notes Payables (2016 - 2023)

ENDRA Life Sciences (NDRA) has reported Notes Payables for 6 consecutive years, with $28484.0 the latest figure, recorded in Q4 2023.

• In Q4 2023, Notes Payables changed 0.0% year-over-year to $28484.0; the TTM figure through Dec 2023 stood at $28484.0 (changed 0.0% YoY), while the FY2023 annual figure was $28484.0, changed 0.0% from the prior year.
• Notes Payables steadied at $28484.0 in Q4 2023 per NDRA's latest filing, from $28484.0 in the prior quarter.
• Across five years, Notes Payables topped out at $590026.0 in Q3 2019 and bottomed at $28484.0 in Q4 2022.
• Historically, Notes Payables has averaged $148633.3 across 4 years, with a median of $28484.0 in 2022.
• On a YoY basis, Notes Payables climbed as much as 0.0% in 2023 and fell as far as 0.0% in 2023.
• ENDRA Life Sciences' Notes Payables stood at $298069.0 in 2019, then plunged by 87.12% to $38402.0 in 2020, then declined by 25.83% to $28484.0 in 2022, then changed by 0.0% to $28484.0 in 2023.
• Business Quant data shows NDRA's Notes Payables at $28484.0 in Q4 2023, $28484.0 in Q3 2023, and $28484.0 in Q2 2023.